MX2013004394A - Composicion farmaceutica topica de mupirocina. - Google Patents

Composicion farmaceutica topica de mupirocina.

Info

Publication number
MX2013004394A
MX2013004394A MX2013004394A MX2013004394A MX2013004394A MX 2013004394 A MX2013004394 A MX 2013004394A MX 2013004394 A MX2013004394 A MX 2013004394A MX 2013004394 A MX2013004394 A MX 2013004394A MX 2013004394 A MX2013004394 A MX 2013004394A
Authority
MX
Mexico
Prior art keywords
group
mupirocin
topical composition
pharmaceutical topical
skin
Prior art date
Application number
MX2013004394A
Other languages
English (en)
Inventor
Ojer Carlos Gonzalez
Allo Beatriz Goni
Fernandez Fiona Pastor
De Miguel Cayetana Yarnoz
Original Assignee
Ojer Pharma S L Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ojer Pharma S L Lab filed Critical Ojer Pharma S L Lab
Publication of MX2013004394A publication Critical patent/MX2013004394A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composición tópica en forma de gel anhidro de mupirocina o sus sales que comprende: a) una base lipófila seleccionada del grupo que consiste en petrolato, triglicéridos de cadena media, miristato de isopropilo y sus mezclas; b) un bioadhesivo seleccionado del grupo que consiste en polivinilpirrolidona y polimetacrilatos; y c) un disolvente seleccionado del grupo que consiste en etanol, propanol e isopropanol; la cual es estable y muestra un mayor tiempo de permanencia del principio activo en la piel, lo cual se traduce en una mayor eficacia clínica en el tratamiento de infecciones cutáneas bacterianas manteniendo el mismo perfil de seguridad que el de un producto farmacéutico de mupirocina ya comercializado.
MX2013004394A 2010-10-20 2011-10-19 Composicion farmaceutica topica de mupirocina. MX2013004394A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10382274A EP2444067A1 (en) 2010-10-20 2010-10-20 Anhydrous gel comprising mupirocin
PCT/EP2011/068242 WO2012052472A1 (en) 2010-10-20 2011-10-19 Pharmaceutical topical composition of mupirocin

Publications (1)

Publication Number Publication Date
MX2013004394A true MX2013004394A (es) 2013-08-21

Family

ID=44050874

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004394A MX2013004394A (es) 2010-10-20 2011-10-19 Composicion farmaceutica topica de mupirocina.

Country Status (16)

Country Link
US (1) US9205149B2 (es)
EP (2) EP2444067A1 (es)
JP (1) JP5954745B2 (es)
KR (1) KR101776362B1 (es)
CN (1) CN103189048B (es)
AU (1) AU2011317636B2 (es)
BR (1) BR112013009371B1 (es)
CA (1) CA2814103C (es)
ES (1) ES2531846T3 (es)
MX (1) MX2013004394A (es)
NZ (1) NZ609655A (es)
PL (1) PL2629756T3 (es)
PT (1) PT2629756E (es)
RU (1) RU2563840C2 (es)
WO (1) WO2012052472A1 (es)
ZA (1) ZA201302560B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014DN11232A (es) * 2012-07-06 2015-10-02 Leo Pharma As
EP2742932A1 (en) 2012-12-17 2014-06-18 Laboratorios Ojer Pharma S.L. Gel compositions
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
CA3033570C (en) * 2015-08-17 2022-12-06 Sidmak Laboratories (India) Pvt. Ltd. Topical film delivery system
KR101717699B1 (ko) 2016-02-11 2017-03-17 아이큐어 주식회사 카타플라스마제용 자외선 경화형 하이드로젤 수지, 하이드로젤 및 이를 포함하는 카타플라스마제
WO2020141482A1 (en) * 2019-01-04 2020-07-09 Glenmark Specialty S.A. Pharmaceutical compositions comprising mupirocin
CN110090198B (zh) * 2019-05-09 2020-02-21 哈尔滨乾佰纳生物药业有限公司 一种具有生物粘附性的缓释型口腔溃疡凝胶及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
GB8615669D0 (en) * 1986-06-26 1986-07-30 Beecham Group Plc Treatment
IE59628B1 (en) 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
GB9321876D0 (en) * 1993-10-22 1993-12-15 Smithkline Beecham Corp Novel composition
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
CA2303443A1 (en) * 1997-09-11 1999-03-18 Anthony Guy Hatton Compositions adapted for prolonged residence in the nasal pharynx
IL137363A (en) 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20050123575A1 (en) * 2003-12-03 2005-06-09 Eilon Asculai Spreadable compositions for topical use, an improved process of making same and methods of using same
KR20070080823A (ko) * 2007-01-31 2007-08-13 주식회사 티디에스팜 활성약물 함유 상처 치료용 하이드로겔 제제

Also Published As

Publication number Publication date
ZA201302560B (en) 2014-06-25
AU2011317636A1 (en) 2013-05-23
JP2013543518A (ja) 2013-12-05
CA2814103A1 (en) 2012-04-26
AU2011317636B2 (en) 2016-05-12
JP5954745B2 (ja) 2016-07-20
KR101776362B1 (ko) 2017-09-07
EP2629756B1 (en) 2014-12-24
NZ609655A (en) 2014-08-29
US20130267587A1 (en) 2013-10-10
RU2013122845A (ru) 2014-11-27
RU2563840C2 (ru) 2015-09-20
PT2629756E (pt) 2015-05-21
BR112013009371B1 (pt) 2019-08-27
WO2012052472A1 (en) 2012-04-26
PL2629756T3 (pl) 2015-06-30
CN103189048B (zh) 2014-11-26
CA2814103C (en) 2018-06-12
US9205149B2 (en) 2015-12-08
CN103189048A (zh) 2013-07-03
BR112013009371A2 (pt) 2016-07-26
EP2444067A1 (en) 2012-04-25
EP2629756A1 (en) 2013-08-28
KR20130124504A (ko) 2013-11-14
ES2531846T3 (es) 2015-03-20

Similar Documents

Publication Publication Date Title
MX2013004394A (es) Composicion farmaceutica topica de mupirocina.
MX2013004099A (es) Conjunto de juguete de construccion.
MX368504B (es) Derivados de amidas y sales farmaceuticamente aceptables de los mismos, método de preparación de los mismos y aplicación médica de los mismos.
NZ631100A (en) Soft chewable pharmaceutical products
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
MY178634A (en) Topical formulation for a jak inhibitor
WO2012017349A3 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
IN2014DN09817A (es)
WO2017025936A3 (en) Composition of lactic bacteria for use in the treatment of infections due to propionibacterium acnes and in particular for acne
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
NZ605469A (en) Nalbuphine-based formulations and uses thereof
PT2459153E (pt) Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
CL2010000524A1 (es) Uso de una composición tópica que comprende 3,75% de imiquimod y un portador farmacéuticamente aceptable para preparar un medicamento útil para tratar verrugas genitales o perianales.
TN2015000282A1 (fr) Composition dermatologique antimicrobienne topique
RU2009131745A (ru) Лекарственное средство для профилактического и/или терапевтического лечения деменции по типу альцгеймера
CY1113885T1 (el) Μια ιατρικη κρεμα φουσιδικου οξεος που παρασκευαζεται με την χρηση φουσιδικου νατριου και ενσωματωση ενος βιοπολυμερους και μια μεθοδος για την παρασκευη της
WO2013092457A3 (de) Wirkstoffkombinationen aus einer oder mehreren carbonsäuren, insbesondere hydroxycarbonsäuren, und einer oder mehreren physiologisch unbedenklichen hydroxamsäure sowie kosmetische oder dermatologische zubereitungen, solche wirkstoffkombinationen enthaltend
SG10201908690WA (en) Novel method of use and compositions
WO2014119985A3 (es) Composición farmacéutica con un inhibidor selectivo de la enzima fosfodiesterasa en forma de gel oral
AR046146A1 (es) Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso
EP4121433A4 (en) BORIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF
AR054361A1 (es) Uso de acido adamantil metoxidifenil propenoico para el tratamiento de enfermedades dermatologicas
WO2012098342A8 (en) (r)-1,2-propanediol for use as a solvent in therapeutic cooling agent compositions
DK1660495T3 (da) Benzoquinolizin-2-carboxylsyreargininsalt,tetrahydrat

Legal Events

Date Code Title Description
FG Grant or registration